Jennifer Tseng, MD
James B. Utley Professor
Boston University Chobanian & Avedisian School of Medicine
Surgery

MD, University of California, San Francisco
MPH, Harvard School of Public Health
BS, Stanford University



Dr. Tseng is a highly regarded surgical oncologist and gastrointestinal surgeon, whose practice encompasses the upper gastrointestinal tract. She has led a group of diverse BIDMC faculty in oncology research, education and care for GI, endocrine, breast, as well as melanomas and sarcomas, and other malignancies.

Dr. Tseng has published more than 100 peer-reviewed journal articles on reducing surgical risk, cancer biomarkers and on developing models for cancer treatment sequencing strategies, with a strong focus on racial and socioeconomic disparities in care, an important BMC and BUSM mission. She has collaborated with the Massachusetts Department of Public Health to assess the impact of factors including insurance, disparities and health care reform on cancer diagnosis, treatment and prevention. She was the Founding Director of SOAR (Surgical Outcomes Analysis & Research) at UMass in 2007, a research initiative to improve treatment strategies for a broad range of surgical conditions and to develop tools to assess and reduce risk. At BIDMC, she and her co-leaders have led the continued development of SOAR as a health services and outcomes research group.

Dr. Tseng is also a dedicated educator of medical students and residents who has mentored numerous trainees throughout her research career.

Chair
Boston University Chobanian & Avedisian School of Medicine
Surgery


Chief
Boston Medical Center
Surgery


Member
Boston University
BU-BMC Cancer Center




Health Care Utilization and Associated Costs Among Older Cancer Survivors
09/01/2022 - 09/30/2023 (Key Person / Mentor)
PI: Kelly Kenzik
American Cancer Society, Inc.




Title


Yr Title Project-Sub Proj Pubs
2001 DEVELOPMENT OF PANCREATIC TUMOR VACCINES 5F32CA086420-02 3
2000 DEVELOPMENT OF PANCREATIC TUMOR VACCINES 1F32CA086420-01 3

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Rasic G, Beaulieu-Jones BR, Chung SH, Romatoski KS, Kenzik K, Ng SC, Tseng JF, Sachs TE. ASO Visual Abstract: The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study. Ann Surg Oncol. 2023 Apr 27; 1-2.View Related Profiles. PMID: 37103726; PMCID: PMC10136382; DOI: 10.1245/s10434-023-13535-y;
     
  2. Rasic G, Beaulieu-Jones BR, Chung SH, Romatoski KS, Kenzik K, Ng SC, Tseng JF, Sachs TE. The Impact of the COVID-19 Pandemic on Hepatocellular Carcinoma Time to Treatment Initiation: A National Cancer Database Study. Ann Surg Oncol. 2023 Apr 26; 1-11.View Related Profiles. PMID: 37099088; PMCID: PMC10132402; DOI: 10.1245/s10434-023-13468-6;
     
  3. Choi PM, Lillemoe KD, Tseng JF, Mammen JMV, Nelles ME, Dossett LA, Funk LM. Emerging From the Pandemic: How Has Academic Surgery Changed? J Surg Res. 2023 Aug; 288:188-192. PMID: 37018895
     
  4. Woods AP, Feeney T, Papageorge MV, de Geus SWL, Tseng JF, Knapp PE, McAneny D, Drake FT. Addressing diagnostic inertia following incidental adrenal mass discovery in patients with hypertension. J Hypertens. 2023 Apr 01; 41(4):680-682.View Related Profiles. PMID: 36878474; PMCID: PMC9996447; DOI: 10.1097/HJH.0000000000003371;
     
  5. Rasic G, de Geus SWL, Papageorge MV, Woods AP, Ng SC, McAneny D, Tseng JF, Sachs TE. Disparities in the Receipt of Recommended Curative Treatment for Patients with Early-Stage Hepatocellular Carcinoma. World J Surg. 2023 Mar 14.View Related Profiles. PMID: 36918443
     
  6. Rasic G, de Geus SWL, Beaulieu-Jones B, Kasumova GG, Kent TS, Ng SC, McAneny D, Tseng JF, Sachs TE. A nationwide propensity score analysis comparing ablation and resection for hepatocellular carcinoma. J Surg Oncol. 2023 Jun; 127(7):1125-1134.View Related Profiles. PMID: 36905338
     
  7. Papageorge MV, de Geus SWL, Woods AP, Ng SC, Lee S, McAneny D, Tseng JF, Kenzik K, Sachs TE. ASO Visual Abstract: Surveillance Patterns for Hepatocellular Carcinoma Among Screening-Eligible Patients in the Medicare Population. Ann Surg Oncol. 2022 Dec; 29(13):8434-8435.View Related Profiles. PMID: 36115926
     
  8. Geary AD, Tseng JF. View From the Chair: The First 5 years. Ann Surg. 2023 Apr 01; 277(4):e730-e732.View Related Profiles. PMID: 36538647
     
  9. Papageorge MV, de Geus SWL, Woods AP, Ng SC, Lee S, McAneny D, Tseng JF, Kenzik KM, Sachs TE. Surveillance Patterns for Hepatocellular Carcinoma among Screening-Eligible Patients in the Medicare Population. Ann Surg Oncol. 2022 Dec; 29(13):8424-8431.View Related Profiles. PMID: 36057903
     
  10. Duraiswamy S, Sanchez SE, Flum DR, Paasche-Orlow MK, Kenzik KM, Tseng JF, Drake FT. Caveat emptor: The accuracy of claims data in appendicitis research. Surgery. 2022 Oct; 172(4):1050-1056.View Related Profiles. PMID: 35985898
     
Showing 10 of 201 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 201 publications over 26 distinct years, with a maximum of 22 publications in 2010

YearPublications
19951
19962
19972
19992
20001
20022
20042
20053
20063
20076
20086
200919
201022
20119
20127
20138
20144
20157
201615
201711
201813
20198
202015
202116
202211
20236
Contact for Mentoring:

88 E. Newton St
Boston MA 02118
Google Map


Tseng's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department